Zhu S, Lu Y, Fei X, Shen K, et al. Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases. Br J Cancer 2023 Aug 21. doi: 10.1038/s41416-023-02403.
PMID: 37604930